Last updated on August 2018

A Study in Adult Patients With Type I III or IV Osteogenesis Imperfecta Treated With BPS804

Brief description of study

The purpose of this study is to select a suitable dose of BPS804 by measuring the strength/quality of bone using a special type of CT scanner. Participants will be treated for 12 months and followed up for a further 12 months.

Clinical Study Identifier: NCT03118570

Contact Investigators or Research Sites near you

Start Over

Ian Hodgson, PhD

Mereo Investigator Site
Lyon, France
  Connect »